United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jul 6, 2026 · Filed Jul 7, 2026

On Jul 6, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$548.96 for US$5.22M under a trading plan, leaving 40,513 shares. Filed Jul 7, 2026 (Form 4).

Sold
9,500 shares
Price
US$548.96 average (US$546.93 to US$553.90)
Value
US$5.22M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 6, 2026Common StockOption exercise9,500US$135.4250,013Direct
Jul 6, 2026Common StockSale2,098US$546.9347,915Direct
Jul 6, 2026Common StockSale1,031US$548.0046,884Direct
Jul 6, 2026Common StockSale3,354US$549.0343,530Direct
Jul 6, 2026Common StockSale2,116US$549.8741,414Direct
Jul 6, 2026Common StockSale329US$550.7841,085Direct
Jul 6, 2026Common StockSale131US$551.8840,954Direct
Jul 6, 2026Common StockSale135US$553.3940,819Direct
Jul 6, 2026Common StockSale306US$553.9040,513Direct

Source

View original at SEC

Related